Wegovy might also increase the risk of thyroid cancer, pancreatitis, gallbladder disease, kidney problems, and diabetic eye disease
One participant lost 22% of her weight in nine months substantially faster than the rate seen with approved GLP-1 drugs like Wegovy or Zepbound
The mechanism of post-prandial increase in GLP-1 level following MBS can be explained by faster gastric emptying and rapid delivery of nutrients to the intestine, exclusion of foregut, and changes in bile acids metabolism [18, 24]
Hanif will discuss alternative weight loss options suited to your health profile and goals whether that means a different medication, a structured nutrition program, metabolic support, or another supervised approach to weight management
Resistance training 34 times weekly is critical to prevent sarcopenia